NO20052794L - Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse - Google Patents

Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse

Info

Publication number
NO20052794L
NO20052794L NO20052794A NO20052794A NO20052794L NO 20052794 L NO20052794 L NO 20052794L NO 20052794 A NO20052794 A NO 20052794A NO 20052794 A NO20052794 A NO 20052794A NO 20052794 L NO20052794 L NO 20052794L
Authority
NO
Norway
Prior art keywords
intermediates
preparation
indoloxazolidinone
antibacterial
pharmaceutical preparations
Prior art date
Application number
NO20052794A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052794D0 (no
Inventor
Toni-Jo Poel
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20052794D0 publication Critical patent/NO20052794D0/no
Publication of NO20052794L publication Critical patent/NO20052794L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
NO20052794A 2003-02-24 2005-06-09 Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse NO20052794L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44973403P 2003-02-24 2003-02-24
PCT/IB2004/000466 WO2004074282A1 (en) 2003-02-24 2004-02-12 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO20052794D0 NO20052794D0 (no) 2005-06-09
NO20052794L true NO20052794L (no) 2005-11-01

Family

ID=32908714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052794A NO20052794L (no) 2003-02-24 2005-06-09 Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse

Country Status (27)

Country Link
US (1) US7012088B2 (is)
EP (1) EP1599470A1 (is)
JP (1) JP3887396B2 (is)
KR (1) KR100701226B1 (is)
CN (1) CN100349892C (is)
AP (1) AP2005003375A0 (is)
AU (1) AU2004213246A1 (is)
BR (1) BRPI0406824A (is)
CA (1) CA2515984A1 (is)
CO (1) CO5601039A2 (is)
CR (1) CR7956A (is)
EA (1) EA009725B1 (is)
EC (1) ECSP055980A (is)
GE (1) GEP20084306B (is)
HK (1) HK1082253A1 (is)
HR (1) HRP20050658A2 (is)
IS (1) IS7883A (is)
MA (1) MA27661A1 (is)
MX (1) MXPA05008960A (is)
NO (1) NO20052794L (is)
OA (1) OA13032A (is)
PL (1) PL377428A1 (is)
RS (1) RS20050649A (is)
TN (1) TNSN05202A1 (is)
UA (1) UA80326C2 (is)
WO (1) WO2004074282A1 (is)
ZA (1) ZA200505225B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
MX2007011873A (es) * 2005-04-06 2007-11-07 Pharmacia & Upjohn Co Llc Una oxindoloxazolidinona como agente antibacteriano.
AU2006231919A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
AU2006244072B2 (en) 2005-05-10 2012-09-20 Intermune, Inc. Pyridone derivatives for modulating stress-activated protein kinase system
WO2007088478A1 (en) * 2006-02-01 2007-08-09 Pfizer Products Inc. Indazole oxazolidinones as antibacterial agents
JP2009526036A (ja) * 2006-02-08 2009-07-16 ファイザー・プロダクツ・インク 抗菌剤としてのオキシインドールを含有するオキサゾリジノン
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
FR2948940B1 (fr) * 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5685384B2 (ja) * 2010-03-29 2015-03-18 公益財団法人相模中央化学研究所 3,3−ジフルオロ−2,3−ジヒドロインドール−2−オン誘導体の製造方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
JP6263124B2 (ja) * 2012-10-17 2018-01-17 国立大学法人 岡山大学 化合物、その互変異性体、幾何異性体、乃至それらの塩、及びそれらの製造方法、抗菌剤、並びに感染症治療薬
CN103193794B (zh) * 2013-04-12 2016-04-06 中国药科大学 一种异吲哚酮并异噁唑类稠环化合物及其合成方法
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones
CN107151225B (zh) * 2017-06-30 2020-05-08 贵州大学 2-羟基吲哚类衍生物、其制备方法和用途
CN113773306B (zh) * 2021-10-29 2023-11-10 四川农业大学 3,3-二取代吲哚酮类化合物及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
EP0609905B1 (en) 1988-09-15 2001-06-06 PHARMACIA & UPJOHN COMPANY 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
HRP960159A2 (en) 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
IL140084A0 (en) 1998-06-05 2002-02-10 Astra Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9812019D0 (en) 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
AU1045300A (en) 1998-11-17 2000-06-05 Bayer Aktiengesellschaft Novel heterocyclyl-substituted oxazolidone derivatives
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
PE20011124A1 (es) 2000-03-31 2001-10-28 Upjohn Co Nuevos agentes antibacterianos de benzosultam oxazolidinona
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US8048386B2 (en) 2002-02-25 2011-11-01 Cepheid Fluid processing and control
PE20030044A1 (es) 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
US7022705B2 (en) 2001-10-25 2006-04-04 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials

Also Published As

Publication number Publication date
EA200501341A1 (ru) 2006-02-24
CA2515984A1 (en) 2004-09-02
WO2004074282A1 (en) 2004-09-02
CN100349892C (zh) 2007-11-21
CR7956A (es) 2005-12-01
US7012088B2 (en) 2006-03-14
AP2005003375A0 (en) 2005-09-30
RS20050649A (en) 2007-11-15
PL377428A1 (pl) 2006-02-06
MA27661A1 (fr) 2005-12-01
TNSN05202A1 (fr) 2007-06-11
HK1082253A1 (en) 2006-06-02
KR20050102135A (ko) 2005-10-25
UA80326C2 (en) 2007-09-10
OA13032A (en) 2006-11-10
EA009725B1 (ru) 2008-02-28
KR100701226B1 (ko) 2007-03-29
NO20052794D0 (no) 2005-06-09
ECSP055980A (es) 2006-01-16
JP2006515012A (ja) 2006-05-18
AU2004213246A1 (en) 2004-09-02
CN1742008A (zh) 2006-03-01
MXPA05008960A (es) 2005-11-04
CO5601039A2 (es) 2006-01-31
HRP20050658A2 (en) 2005-12-31
IS7883A (is) 2005-06-09
EP1599470A1 (en) 2005-11-30
ZA200505225B (en) 2006-11-29
BRPI0406824A (pt) 2005-12-27
US20040176610A1 (en) 2004-09-09
GEP20084306B (en) 2008-02-11
JP3887396B2 (ja) 2007-02-28

Similar Documents

Publication Publication Date Title
NO20052794L (no) Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse
SE0301700D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
SE0202539D0 (sv) Compounds
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
SE0302811D0 (sv) Novel compounds
SE0104140D0 (sv) Novel Compounds
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20055010D0 (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MY128924A (en) Novel compounds
ATE338550T1 (de) Mikronisierter zolpidem hemitartrat
SE0302139D0 (sv) Novel compounds
ATE300541T1 (de) Pyrazolopyridinderivate
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
SE0102716D0 (sv) Novel compounds
SE9804212D0 (sv) Compounds
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
SE0303280D0 (sv) Novel compounds
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
ATE274515T1 (de) Pyrazolopyridinderivate
NO20044466L (no) Plasma-karboksypeptidase B-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application